No one kills the goose that lays the golden Egg

In June 1974, one of the first UPC scanner, made by National Cash Register Co , was installed at Marsh's supermarket in Troy, Ohio. On June 26, 1974, the first product with a bar code was a 10-pack of Wrigley's Juicy Fruit chewing gum.

Today, every product in supermarkets has a barcode or can be bar-coded. Grocery bar-coding came under fire from all sorts of new technologies (RFID, Tags….)but it came out victories, because it is cost effective.

The pharmacists are new to bar-coding, as late as 2007, The U.S. Food and Drug Administration (FDA) has "proposed" supermarket-style barcodes on every medication. While, the Europeans declared that by 2011 every medicine should have a code on every pack of medicine,

Now, it is becoming a playground for high Tech IT Multinational Network, trying to introduce very expensive, and sophisticated coding system into the industry by brutal force.

labeling companies are ready for mass Drug serialization and E-pedigee.This means ," the printing of a unique Label on each product linked to a central data repository via a network ", leaving the medical industry completely confused ,and divided.

The deadline has been extended four times, many countries, were used as pilot test (turkey example , but they received 250 million grants for the test, )

Despite the ticking of the clock, many pharmaceutical manufacturers still haven’t begun preparations because of the millions of dollars it would take to do so. Very few want to invest time and money into something they view as uncertain.

Barcode Dilemma

Why barcode while the volume of sale in Pharmacies are small compared to Supermarkets and also an over qualified person picks the item from the shelf instead of the customer.

There are two concerns. The Medical industry is concerned with patient safety , that too many patients were receiving the wrong drug at hospital bedsides. and fake drugs, Therefore a system of identification ( ID ) is needed as well as system of verification to halt fake drugs

The dilemma in the Drug Industry is the need for a medical code to carry additional information like (Expiry Date the Batch Number,…). Therefore the code carrier (the barcode) must be high density barcode-like 2D Data Matrix or Color Barcode. (Although the Chinese are using linear 120C)

The second concern is verification to stop fake drug entering the legitimate supply chain, Therefore they proposed a system to track the item from the manufacturer to the user, and trace each item back to the manufacturer.( of course , this is of tremendous benefits for the manufacturers, and turns the pharmacists legally responsible for any fake drug in the system, )

However The state of California has taken the lead and they have enacted what is called an “e-Pedigree” requirement. Under the “e-Pedigree,” pharmaceutical companies must encode a barcode with serial number, lot number, and other ensuring that each individual package can be tracked and traced throughout its supply chain lifespan.

It is possible to fit this information into a linear barcode, but doing so would make the label on the package an awkwardly large size. Instead, manufacturers who want to comply with the California law must turn to space-saving 2D barcodes such as GS1 DataMatrix

Now most governments are requiring serial number. And while pharmaceutical companies can obtain a serial number from the GS1 (a Global Trade Item number, or GTIN), this number can not be added to a standard UPC barcode commonly used on most items

Globally harmonized drug system

Many countries are developing their own systems . As an example, China’s issuance of its own government-issued national-product identifiers (EDMC [Electronic Drug Monitoring Code]), rather than supporting and adopting a global standard, like GS1, for product identification and hierarchy (GTIN, GLN, SSCC).”. and in item-level serialization should occur. The authentication process checks the validity of the serial number at the point the drug is dispensed to the patient, not during its travels. “we need to ensure that the cost of the solution is not more costly than the problem.”

Geography is also another issue California’s ePedigree is , requiring pharmaceutical manufacturers and packagers to serialize drugs down to a unit level in order to sell in the state. . The EU requirements for serialisation come into force in 2019 , the process of incorporating serialization into a production line is complex and time-consuming, particularly if you are supplying to multiple markets with varying regulations.

Many factors can vary from country to country. Although many markets require GS1 standard barcodes, there are exceptions. Companies supplying to China must serialize their products with a linear barcode, while the Brazilian market requires a 2D data matrix with human readable information, including a unique identifier, a batch number, a registration number and expiry information.

The idea of Bar-coding in the medical industry has been hijacked by the multinational drug companies and the IT industry. Although there are a lot of Data carriers, including our Color Barcode, but be assured that with modern technology, to have 2D Barcodes and color-bar codes are no longer necessary. Our approach is based on the design of the Medical code rather than the carrier of the code

Therefore, I suggest to develop our system , and by the end of 2018, the prove of the budding is in the eating. The advocates of 2D are becoming too powerful pressure group, but as I said in 2010 , that the system aims at creating problems for new-comers into the industry. Serial number if SN is used then all informations are redundaent, and a liner code is more than sufficient simply because you have to be linled to the data base to complete the transction,.even if a batch nume is used with certain modification

The idea of bar-coding is being hijacked, by the multination drug companies, and used for tracking there products and stopping counterfeit of their medicines

With Mass serialization you are in effect asking the Small drug manufacturers, to invest in labeling themselves out of the drug market, in order to protect the branded drugs of the major companies from being faked .Why?

Pedigree – a huge database housing all transactions in the supply ,will be used to convert the warehouses, the pharmacists, into unpaid police and detectives legally responsible for any fake drugs in the system… The effect of the mass serialization and pedigree will have profound effect on the structure of pharmaceutical industry, turning it into big a Drug Car

Our Solution

During the last three years we were beating around the wrong bush, looking for a suitable barcode, for this sector, believing that might end the coding confusion and also solve the problem of drug counterfeit .but we discovered that Barcodes in the Pharmaceutical Sector are not as important as it is in the Groceries


80% of seizures of counterfeit brands are traced back to where the drug Manufacturers, outsourced the manufacturing of their brand to Asian countries to produce under license. as predation strategy

Our message is simple : Barcode alone cannot solve the problems. see our solution


The dilemma is not how to find and an acceptable Drugcode and a suitable data container, On the contrary, the problem is that we have too many National Drug Codes and Data Carriers.. The problem is that the Pharmaceutical industry, is becoming very competitive, and drug production has become off the shelve technology with cost of production going down drastically and to maintain GMP is much cheaper and brand loyalty is disappearing

The present track and trace system, although it will not reduce counterfeit ( The dollar is being faked), but it will be a barrier for new comers into the industry, and a system of policing brands with pharmacist as police and defective free of charge for multinational drug manufacturer

Let us prepare our system before having a conference to announce it in June 2018.

The solution is cost effective harmonized coding system which helps to create The Health Information Technology rather than helping the big manufacturers getting bigger , by introducing restrictive practices